Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Farmers Insurance
Medtronic
Boehringer Ingelheim
QuintilesIMS
US Army
Accenture
UBS
Argus Health
Baxter

Generated: January 21, 2018

DrugPatentWatch Database Preview

XURIDEN Drug Profile

« Back to Dashboard

When do Xuriden patents expire, and when can generic versions of Xuriden launch?

Xuriden is a drug marketed by Wellstat Therap and is included in one NDA. There is one patent protecting this drug.

This drug has one hundred and seventy-five patent family members in twenty-one countries.

The generic ingredient in XURIDEN is uridine triacetate. There are thirty-five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the uridine triacetate profile page.
Summary for XURIDEN
Drug patent expirations by year for XURIDEN
Pharmacology for XURIDEN

US Patents and Regulatory Information for XURIDEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wellstat Therap XURIDEN uridine triacetate GRANULE;ORAL 208169-001 Sep 4, 2015 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Wellstat Therap XURIDEN uridine triacetate GRANULE;ORAL 208169-001 Sep 4, 2015 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wellstat Therap XURIDEN uridine triacetate GRANULE;ORAL 208169-001 Sep 4, 2015 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for XURIDEN

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
5,736,531 Compositions of chemotherapeutic agent or antiviral agent with acylated pyrimidine nucleosides ➤ Subscribe
6,060,459 Enhancing blood cell count with oxypurine nucleosides ➤ Subscribe
6,344,447 Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides ➤ Subscribe
5,246,708 Methods for promoting wound healing with deoxyribonucleosides ➤ Subscribe
6,919,320 Pharmaceutical compositions containing deoxyribonucleosides for wound healing ➤ Subscribe
6,348,451 Acyl deoxyribonucleoside derivatives and uses thereof ➤ Subscribe
6,020,320 Acyl deoxyribonucleoside derivatives and uses thereof ➤ Subscribe
6,297,222 Acyl deoxyribonucleoside derivatives and uses thereof ➤ Subscribe
6,274,563 Acylated uridine and cytidine and uses thereof ➤ Subscribe
6,103,701 Method for enhancing hematopoiesis with acyl deoxyribonucleosides ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for XURIDEN

Supplementary Protection Certificates for XURIDEN

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0889 Netherlands ➤ Subscribe PRODUCT NAME: TRIFLURIDINE IN COMBINATIE MET TIPIRACIL OF EEN ZOUT VAN TIPIRACIL, ZOALS TIPIRACILHYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/16/1096 20160427
2017 00036 Denmark ➤ Subscribe PRODUCT NAME: TRIFLURIDINE IN COMBINATION WITH TIPIRACIL OR A PHARMACEUTICALLY ACCEPTABLE SALT OF TIPIRACIL; REG. NO/DATE: EU/1/16/1096 20160427
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Farmers Insurance
Federal Trade Commission
Julphar
Deloitte
US Army
Fuji
Chubb
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot